Stay updated on KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer

Sign up to get notified when there's something new on the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page.
Latest website image capture
Clouds background image

Latest updates to the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page

  1. Check
    6 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-19T21:52:13.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The website has updated the intervention details, confirming the status as 'Recruiting' and revising the version to v2.14.0, while removing previous contact information and the earlier version v2.13.3.
    Difference
    1%
    Check dated 2025-01-12T17:33:39.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    No Change Detected
  6. Check
    42 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T22:38:27.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with a reference to the Contacts and Locations section.
    Difference
    2%
    Check dated 2024-12-07T15:54:41.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Several key resources related to genetics and breast cancer have been removed, including links to MedlinePlus and PubMed articles, which may impact access to important health information.
    Difference
    3%
    Check dated 2024-11-23T04:31:27.000Z thumbnail image
  9. Check
    71 days ago
    Change Detected
    Summary
    New resources related to breast cancer and Pembrolizumab have been added, including links to MedlinePlus and PubMed, which may be of particular interest to users seeking updated medical information.
    Difference
    0.4%
    Check dated 2024-11-15T23:36:33.000Z thumbnail image

Stay in the know with updates to KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer

Enter your email address, and we'll notify you when there's something new on the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page.